Condition
Germ Cell Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 19 Germ Cell Tumor clinical trials that are recruiting, at sites in 25 countries (most in United States (12), United Kingdom (4), China (3)). By phase: Phase 1 (4), Phase 2 (4), Phase 3 (3), Early Phase 1 (1). The most active sponsors are Children's Oncology Group (2), Indiana University (2). There are also 2 NIH-funded research projects on Germ Cell Tumor, with $479,161 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 19Clinical trials
- 2NIH research projects
- 25Countries
Newest Germ Cell Tumor clinical trials
All recruiting trials (19)
-
Methionine-Reduced Diet in Solid Tumors (early-phase)
A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.
-
Teniposide plus cisplatin for newly diagnosed central malignant germ cell tumors
This trial tests whether giving teniposide together with cisplatin helps people newly diagnosed with central malignant germ cell tumors.
-
ZW251 for advanced liver, lung, and germ cell cancers
This will test whether ZW251, an antibody-drug conjugate that targets GPC3, is safe and can shrink tumors in adults with advanced hepatocellular carcinoma, squamous cell non-small cell lung cancer, or germ cell tumors.
-
Maintenance zanzalintinib with oral etoposide after high-dose chemotherapy for germ cell tumor
This treatment tests whether daily zanzalintinib together with cycles of oral etoposide can help people with relapsed or refractory germ cell tumors after high-dose chemotherapy and stem-cell transplant.
-
Low-dose aspirin to prevent venous blood clots during chemotherapy for advanced germ cell (testicular) cancer
This trial will see if taking one daily low-dose aspirin (81 mg) during cisplatin chemotherapy prevents venous blood clots over six months in adults up to age 70 with high-risk advanced germ cell or testicular cancer.
-
Creating a database for mediastinal tumors at Peking Union Medical College Hospital
This study is creating a database to help doctors better understand and treat different types of mediastinal tumors by collecting information on their characteristics and imaging results.
-
High-dose chemotherapy for relapsed germ cell tumors
This study is testing if high-dose chemotherapy can help people with relapsed germ cell tumors who didn't respond to their first treatment feel better and live longer.
-
Safety and tolerability of XmAb541 in patients with advanced solid tumors
This study is testing a new drug called XmAb541 to see if it's safe and how well it works for people with advanced solid tumors like ovarian and endometrial cancer.
-
Robot-assisted biopsy for testicular cancer
This study is testing a new robot-assisted method for taking biopsies in men with testicular cancer to see if it can more accurately find hidden cancer and reduce unnecessary treatments.
-
Preventing blood clots in patients with advanced germ cell tumors undergoing chemotherapy
This study is testing whether a blood clot prevention treatment can help people with advanced germ cell tumors who are getting chemotherapy avoid serious blood clots.
-
Investigating genetic and molecular profiles of pediatric brain tumors in China
This study is trying to understand the genetic makeup of brain tumors in children to see how it affects their treatment and recovery.
-
Understanding the long-term effects of pediatric germ cell tumors
This study is trying to understand the long-term effects of treatment on kids and teens who survived germ cell tumors to see how their health might change over time.
-
Observational assessment of treatment outcomes for patients with primary brain tumors
This study looks at how well treatments work for people with rare primary brain tumors using new classification guidelines to see if they help doctors group patients better.
-
Oral etoposide versus observation after high-dose chemotherapy for relapsed germ cell tumors
This study is testing if taking daily oral etoposide after high-dose chemotherapy can help people with relapsed germ cell tumors do better than just watching and waiting.
-
Combining vorinostat with chemotherapy for relapsed solid tumors and CNS cancers
This study is testing if adding a drug called vorinostat to chemotherapy can help people with relapsed solid tumors and brain cancers feel better and improve their treatment outcomes.
-
Locoregional immunotherapy using CAR T cells for pediatric brain tumors
This study is testing a new treatment using specially modified immune cells to see if it can help children and young adults with certain types of brain tumors feel better.
-
Monitoring and treating germ cell tumors in children and adults
This study is testing whether a combination of careful monitoring and chemotherapy can help children and adults with low-risk germ cell tumors stay healthy after surgery, while also comparing two different chemotherapy drugs and looking at their effects on hearing.
-
Accelerated versus standard BEP chemotherapy for intermediate and poor‑risk metastatic germ cell tumours
This trial will test whether giving BEP chemotherapy every 2 weeks instead of every 3 weeks helps males (typically aged 11–50) with intermediate- or poor‑risk metastatic germ cell tumours do better.
-
Registry for Germ Cell and Testicular Tumors
This study is trying to gather information from people with germ cell and testicular tumors, their families, and healthy individuals to better understand how these tumors develop and how to treat them.
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
How mistakes in egg cell division can cause infertility and germ cell tumors
Researchers are studying how errors in the last steps of egg cell division can lead to eggs that can't be fertilized, miscarriages, or germ cell tumors.
-
Understanding the genetic causes of testicular germ cell tumors in children and adults
This study is looking at how certain genes might play a role in testicular cancer, especially in young men and boys with unique genital conditions, to help find better ways to prevent and treat this type of cancer in the future.
Related topics
Quick answers
How many Germ Cell Tumor clinical trials are recruiting right now?
19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 25 countries. The most sites are in United States (12 trials), United Kingdom (4 trials), China (3 trials), Spain (3 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 2: 4, Phase 3: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.